Protagenic Therapeutics, Inc.\new SEC filings PTIX

Protagenic Therapeutics, Inc.\new has 705 filings in SEC EDGAR's recent list, going back to Oct 22, 1996. Its latest annual report, Form 10-K, was filed on Aug 14, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 19, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 20, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on March 31.

Protagenic Therapeutics, Inc.\new SEC filings
Form Description Filed Period
10-K Annual report Aug 14, 2026 Mar 31, 2026
10-K Annual report Mar 31, 2025 Dec 31, 2024
10-K/A Amended annual report May 14, 2024 Dec 31, 2023
10-K/A Amended annual report Apr 24, 2024 Dec 31, 2023
10-K Annual report Apr 1, 2024 Dec 31, 2023
10-K/A Amended annual report Apr 17, 2023 Dec 31, 2022
10-K Annual report Mar 31, 2023 Dec 31, 2022
10-K Annual report Apr 7, 2022 Dec 31, 2021
10-K Annual report Mar 25, 2021 Dec 31, 2020
10-K Annual report Apr 29, 2020 Dec 31, 2019
10-K/A Amended annual report Jul 3, 2019 Dec 31, 2018
10-K Annual report Mar 29, 2019 Dec 31, 2018
10-K/A Amended annual report Apr 5, 2018 Dec 31, 2017
10-K Annual report Apr 2, 2018 Dec 31, 2017
10-K/A Amended annual report May 8, 2017 Dec 31, 2016
10-K Annual report Apr 18, 2017 Dec 31, 2016
10-K Annual report Sep 25, 2015 Jun 30, 2015
10-K Annual report Oct 14, 2014 Jun 30, 2014
10-K/A Amended annual report May 2, 2011 Dec 31, 2010
10-K Annual report Apr 7, 2011 Dec 31, 2010
10-K/A Amended annual report Apr 30, 2010 Dec 31, 2009
10-K Annual report Mar 31, 2010 Dec 31, 2009
10-K Annual report Mar 27, 2009 Dec 31, 2008

Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PTIX (OTC)
Fiscal year ends
March 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1022899
Former names
Atrinsic, Inc. (until Jun 20, 2016); NEW MOTION, INC. (until Jun 30, 2009); MPLC, Inc. (until Apr 2, 2007); MILLBROOK PRESS INC (until May 23, 2005)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.